| Thomas Ryan Birris, MD | |
|
3903 Hollywood Rd, Saint Joseph, MI 49085-9149 | |
| (269) 408-1100 | |
| Not Available |
| Full Name | Thomas Ryan Birris |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 19 Years |
| Location | 3903 Hollywood Rd, Saint Joseph, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003083627 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 036120897 (Illinois) | Secondary |
| 207RG0100X | Internal Medicine - Gastroenterology | 4301100025 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lakeland Hospital, St Joseph | St joseph, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lakeland Medical Practices | 1658427042 | 274 |
| Great Lakes Gastroenterology Pllc | 6103927702 | 4 |
News Archive
RegeneRx Biopharmaceuticals, Inc. has announced that researchers have found that Thymosin beta 4 (Tβ4), in a dose dependent manner, stimulates oligodendrogenesis, the process by which central nervous system progenitor cells become oligodendrocytes that secrete myelin, the covering of nerve fibers.
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that its new oral anticoagulant, Pradaxa® (dabigatran etexilate mesylate) 150mg capsules, will be available starting Wednesday by prescription in pharmacies across the United States, including CVS/pharmacy, Rite Aid, Walmart, Target, Kmart® and The Kroger Co. In addition, leading independents under the Health Mart®, Good Neighbor Pharmacy® and Medicine Shoppe® banners will be stocked.
Federal officials and health policy experts believe that electronic health records (EHRs) will improve patient care. Researchers measured adherence to diabetes care guidelines as well as patient outcomes over three years at 16 practices using EHRs and 26 practices using paper records. Practices with EHRs did not show signs of better care and providers using them "have not made the necessary changes to both work processes and ways of thinking about care that would lead to improvements in chronic illness management."
CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) to extend the shelf life of Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid, from 18 months to 24 months. Hizentra, the first and only 20 percent subcutaneous immunoglobulin (SCIg) approved in the U.S. by the FDA, is also the first and only SCIg in the U.S. that may be stored at room temperature.
Oncolytics Biotech Inc. announced today that the Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute (NCI), which is part of the National Institutes of Health, has agreed to sponsor a 2-Arm randomized Phase II study of carboplatin, paclitaxel plus REOLYSIN® versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer.
› Verified 9 days ago
| Entity Name | Great Lakes Gastroenterology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780691899 PECOS PAC ID: 6103927702 Enrollment ID: O20070726000550 |
News Archive
RegeneRx Biopharmaceuticals, Inc. has announced that researchers have found that Thymosin beta 4 (Tβ4), in a dose dependent manner, stimulates oligodendrogenesis, the process by which central nervous system progenitor cells become oligodendrocytes that secrete myelin, the covering of nerve fibers.
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that its new oral anticoagulant, Pradaxa® (dabigatran etexilate mesylate) 150mg capsules, will be available starting Wednesday by prescription in pharmacies across the United States, including CVS/pharmacy, Rite Aid, Walmart, Target, Kmart® and The Kroger Co. In addition, leading independents under the Health Mart®, Good Neighbor Pharmacy® and Medicine Shoppe® banners will be stocked.
Federal officials and health policy experts believe that electronic health records (EHRs) will improve patient care. Researchers measured adherence to diabetes care guidelines as well as patient outcomes over three years at 16 practices using EHRs and 26 practices using paper records. Practices with EHRs did not show signs of better care and providers using them "have not made the necessary changes to both work processes and ways of thinking about care that would lead to improvements in chronic illness management."
CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) to extend the shelf life of Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid, from 18 months to 24 months. Hizentra, the first and only 20 percent subcutaneous immunoglobulin (SCIg) approved in the U.S. by the FDA, is also the first and only SCIg in the U.S. that may be stored at room temperature.
Oncolytics Biotech Inc. announced today that the Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute (NCI), which is part of the National Institutes of Health, has agreed to sponsor a 2-Arm randomized Phase II study of carboplatin, paclitaxel plus REOLYSIN® versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer.
› Verified 9 days ago
| Entity Name | Lakeland Medical Practices |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538397120 PECOS PAC ID: 1658427042 Enrollment ID: O20090928000216 |
News Archive
RegeneRx Biopharmaceuticals, Inc. has announced that researchers have found that Thymosin beta 4 (Tβ4), in a dose dependent manner, stimulates oligodendrogenesis, the process by which central nervous system progenitor cells become oligodendrocytes that secrete myelin, the covering of nerve fibers.
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that its new oral anticoagulant, Pradaxa® (dabigatran etexilate mesylate) 150mg capsules, will be available starting Wednesday by prescription in pharmacies across the United States, including CVS/pharmacy, Rite Aid, Walmart, Target, Kmart® and The Kroger Co. In addition, leading independents under the Health Mart®, Good Neighbor Pharmacy® and Medicine Shoppe® banners will be stocked.
Federal officials and health policy experts believe that electronic health records (EHRs) will improve patient care. Researchers measured adherence to diabetes care guidelines as well as patient outcomes over three years at 16 practices using EHRs and 26 practices using paper records. Practices with EHRs did not show signs of better care and providers using them "have not made the necessary changes to both work processes and ways of thinking about care that would lead to improvements in chronic illness management."
CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) to extend the shelf life of Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid, from 18 months to 24 months. Hizentra, the first and only 20 percent subcutaneous immunoglobulin (SCIg) approved in the U.S. by the FDA, is also the first and only SCIg in the U.S. that may be stored at room temperature.
Oncolytics Biotech Inc. announced today that the Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute (NCI), which is part of the National Institutes of Health, has agreed to sponsor a 2-Arm randomized Phase II study of carboplatin, paclitaxel plus REOLYSIN® versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Ryan Birris, MD 3903 Hollywood Rd, Saint Joseph, MI 49085-9149 Ph: () - | Thomas Ryan Birris, MD 3903 Hollywood Rd, Saint Joseph, MI 49085-9149 Ph: (269) 408-1100 |
News Archive
RegeneRx Biopharmaceuticals, Inc. has announced that researchers have found that Thymosin beta 4 (Tβ4), in a dose dependent manner, stimulates oligodendrogenesis, the process by which central nervous system progenitor cells become oligodendrocytes that secrete myelin, the covering of nerve fibers.
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that its new oral anticoagulant, Pradaxa® (dabigatran etexilate mesylate) 150mg capsules, will be available starting Wednesday by prescription in pharmacies across the United States, including CVS/pharmacy, Rite Aid, Walmart, Target, Kmart® and The Kroger Co. In addition, leading independents under the Health Mart®, Good Neighbor Pharmacy® and Medicine Shoppe® banners will be stocked.
Federal officials and health policy experts believe that electronic health records (EHRs) will improve patient care. Researchers measured adherence to diabetes care guidelines as well as patient outcomes over three years at 16 practices using EHRs and 26 practices using paper records. Practices with EHRs did not show signs of better care and providers using them "have not made the necessary changes to both work processes and ways of thinking about care that would lead to improvements in chronic illness management."
CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) to extend the shelf life of Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid, from 18 months to 24 months. Hizentra, the first and only 20 percent subcutaneous immunoglobulin (SCIg) approved in the U.S. by the FDA, is also the first and only SCIg in the U.S. that may be stored at room temperature.
Oncolytics Biotech Inc. announced today that the Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute (NCI), which is part of the National Institutes of Health, has agreed to sponsor a 2-Arm randomized Phase II study of carboplatin, paclitaxel plus REOLYSIN® versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer.
› Verified 9 days ago
Hany S Mesiha, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1234 Napier Ave, Saint Joseph, MI 49085 Phone: 269-983-8300 | |
Kimberlee Ann Tomerlin, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3950 Hollywood Rd Ste 100, Saint Joseph, MI 49085 Phone: 269-429-8010 | |
Dr. Robert M Allen, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1234 Napier Ave, Saint Joseph, MI 49085 Phone: 269-471-7741 Fax: 269-471-1581 | |
Michael Scott Morris, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1234 Napier Ave, Saint Joseph, MI 49085 Phone: 269-982-4862 Fax: 269-985-4523 | |
Dr. Yu-lam Christopher Chiu, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3950 Hollywood Rd, Suite 110, Saint Joseph, MI 49085 Phone: 269-985-1000 Fax: 269-983-1627 | |
Dr. Anthony P Salvagione, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 820 Lester Ave, Saint Joseph, MI 49085 Phone: 269-985-0029 Fax: 269-985-0040 |